Marijuana use and motor vehicle crashes.

Since 1996, 16 states and the District of Columbia in the United States have enacted legislation to decriminalize marijuana for medical use. Although marijuana is the most commonly detected nonalcohol drug in drivers, its role in crash causation remains unsettled. To assess the association between marijuana use and crash risk, the authors performed a meta-analysis of 9 epidemiologic studies published in English in the past 2 decades identified through a systematic search of bibliographic databases. Estimated odds ratios relating marijuana use to crash risk reported in these studies ranged from 0.85 to 7.16. Pooled analysis based on the random-effects model yielded a summary odds ratio of 2.66 (95% confidence interval: 2.07, 3.41). Analysis of individual studies indicated that the heightened risk of crash involvement associated with marijuana use persisted after adjustment for confounding variables and that the risk of crash involvement increased in a dose-response fashion with the concentration of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol detected in the urine and the frequency of self-reported marijuana use. The results of this meta-analysis suggest that marijuana use by drivers is associated with a significantly increased risk of being involved in motor vehicle crashes.

[1]  D. Hoffmann,et al.  Medical marijuana and the law. , 2010, The New England journal of medicine.

[2]  J K Wells,et al.  Drugs in fatally injured young male drivers. , 1985, Public health reports.

[3]  R. Sansone,et al.  Driving on antidepressants: cruising for a crash? , 2009, Psychiatry (Edgmont (Pa. : Township)).

[4]  A. Chang,et al.  Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. , 1979, Annals of internal medicine.

[5]  A. Egberts,et al.  The Relationship between Benzodiazepine Use and Traffic Accidents , 2010, CNS drugs.

[6]  A. Pastor,et al.  Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. , 2010, British journal of clinical pharmacology.

[7]  L J Horwood,et al.  Cannabis use and traffic accidents in a birth cohort of young adults. , 2001, Accident; analysis and prevention.

[8]  E. Kelly,et al.  A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. , 2004, Drug and alcohol review.

[9]  Kaladhar Voruganti,et al.  Volume I , 2005, Proceedings of the Ninth International Conference on Computer Supported Cooperative Work in Design, 2005..

[10]  W. Tormey.  Adverse health effects of non-medical cannabis use , 2010, The Lancet.

[11]  S. Werness,et al.  Short‐term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers , 1994, Clinical pharmacology and therapeutics.

[12]  J. Zajicek,et al.  Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis ( CAMS study ) : multicentre randomised placebo-controlled trial , 2022 .

[13]  P. Macintyre,et al.  Driving Behavior Under the Influence of Cannabis or Cocaine , 2008, Traffic injury prevention.

[14]  A. Hathaway,et al.  Injury risk associated with cannabis and cocaine use. , 2003, Drug and alcohol dependence.

[15]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[16]  Mark Asbridge,et al.  Motor vehicle collision risk and driving under the influence of cannabis: evidence from adolescents in Atlantic Canada. , 2005, Accident; analysis and prevention.

[17]  P. J. Cohen,et al.  Medical Marijuana: The Conflict Between Scientific Evidence and Political Ideology. Part One of Two , 2009, Journal of pain & palliative care pharmacotherapy.

[18]  H. Moskowitz,et al.  Marihuana and driving. , 1985, Accident; analysis and prevention.

[19]  P. Swann,et al.  The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. , 2004, Accident; analysis and prevention.

[20]  P. Cohen.  Medical Marijuana: The Conflict Between Scientific Evidence and Political Ideology. Part Two of Two , 2009, Journal of pain & palliative care pharmacotherapy.

[21]  A. Egberts,et al.  Psychoactive substance use and the risk of motor vehicle accidents. , 2004, Accident; analysis and prevention.

[22]  T. Blakely,et al.  Role of cannabis in motor vehicle crashes. , 1999, Epidemiologic reviews.

[23]  James Poling,et al.  The effect of cannabis compared with alcohol on driving. , 2009, The American journal on addictions.

[24]  Patrick M O'Malley,et al.  Drugs and driving by American high school seniors, 2001-2006. , 2007, Journal of studies on alcohol and drugs.

[25]  P. J. Cohen,et al.  Medical Marijuana 2010: It's Time to Fix the Regulatory Vacuum , 2010, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

[26]  G. Bennett,et al.  Smoked cannabis for chronic neuropathic pain: a randomized controlled trial , 2010, Canadian Medical Association Journal.

[27]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[28]  Randolph Atkins,et al.  Drug and alcohol use among drivers admitted to a Level-1 trauma center. , 2005, Accident; analysis and prevention.

[29]  C. Reinarman,et al.  The limited relevance of drug policy: cannabis in Amsterdam and in San Francisco. , 2004, American journal of public health.

[30]  A. Smiley,et al.  Developing limits for driving under cannabis. , 2007, Addiction.

[31]  Anders Engeland,et al.  Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. , 2008, Sleep medicine.

[32]  George Davey Smith,et al.  Misleading meta-analysis , 1995, BMJ.

[33]  J. G. Perry,et al.  DRUGS AND DRIVING , 1980 .

[34]  W. J. Crawford,et al.  Effect of marihuana on intraocular and blood pressure in glaucoma. , 1980, Ophthalmology.

[35]  W. Hall,et al.  The adverse effects of cannabinoids: implications for use of medical marijuana , 2008, Canadian Medical Association Journal.

[36]  D Shinar,et al.  STATE OF KNOWLEDGE OF DRUG-IMPAIRED DRIVING , 2003 .

[37]  P. Suriyawongpaisal,et al.  Alcohol, illicit and non-illicit psychoactive drug use and road traffic injury in Thailand: a case-control study. , 2009, Accident; analysis and prevention.

[38]  James A. Kaplan,et al.  Alcohol and other drug use among victims of motor-vehicle crashes--West Virginia, 2004-2005. , 2006, MMWR. Morbidity and mortality weekly report.

[39]  B Ludes,et al.  Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. , 2003, Forensic science international.

[40]  M. Rowbotham,et al.  Cannabis in painful HIV-associated sensory neuropathy , 2007, Neurology.

[41]  M. Weatherall,et al.  Effects of cannabis on pulmonary structure, function and symptoms , 2007, Thorax.

[42]  K I Bolla,et al.  Dose-related neurocognitive effects of marijuana use , 2002, Neurology.

[43]  Thomas Babor,et al.  Cognitive functioning of long-term heavy cannabis users seeking treatment. , 2002, JAMA.

[44]  Randolph Atkins,et al.  Epidemiology of Alcohol and Other Drug Use Among Motor Vehicle Crash Victims Admitted to a Trauma Center , 2004, Traffic injury prevention.

[45]  Susan Goodwin Gerberich,et al.  Marijuana use and injury events resulting in hospitalization. , 2003, Annals of epidemiology.

[46]  Mark W. Lipsey,et al.  Practical Meta-Analysis , 2000 .

[47]  P. J. Cohen,et al.  Medical Marijuana: The Conflict Between Scientific Evidence and Political Ideology. Part Two of Two , 2009, Journal of pain & palliative care pharmacotherapy.

[48]  M. Woodward,et al.  Marijuana use and car crash injury. , 2005, Addiction.

[49]  S. Fishman,et al.  A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. , 2008, The journal of pain : official journal of the American Pain Society.

[50]  Anders Engeland,et al.  Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. , 2007, Annals of epidemiology.

[51]  S. Watson,et al.  Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report. , 2000, Archives of general psychiatry.

[52]  A. Chang,et al.  A prospective evaluation of delta‐9‐tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy , 1981, Cancer.

[53]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[54]  Robert B. Voas,et al.  2007 National Roadside Survey of Alcohol and Drug Use by Drivers: Alcohol Results , 2009 .

[55]  G. Carter,et al.  Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions. , 2018, Journal of opioid management.

[56]  A. Thompson,et al.  Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[57]  S. Daniel,et al.  National Highway Traffic Safety Administration , 2020, Federal Regulatory Guide.

[58]  M Brault,et al.  The Contribution of Alcohol and Other Drugs Among Fatally Injured Drivers in Quebec: Final Results , 2004 .

[59]  H. Robbe,et al.  Marijuana's impairing effects on driving are moderate when taken alone but severe when combined with alcohol , 1998 .

[60]  M. Namaka,et al.  Examining the roles of cannabinoids in pain and other therapeutic indications: a review , 2010, Expert opinion on pharmacotherapy.

[61]  P. Philip,et al.  The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies , 2009, Pharmacoepidemiology and Drug Safety.

[62]  G. Cabral,et al.  Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease , 1998, Journal of Neuroimmunology.

[63]  J. L. R. Martin,et al.  Systematic review and meta-analysis of cannabis treatment for chronic pain. , 2009, Pain medicine.

[64]  F. Vaida,et al.  Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial , 2009, Neuropsychopharmacology.

[65]  J. Collet,et al.  Adverse effects of medical cannabinoids: a systematic review , 2008, Canadian Medical Association Journal.

[66]  B. Martin.  Medical marijuana—moving beyond the smoke , 2002, The Lancet.

[67]  J. Ramaekers,et al.  Dose related risk of motor vehicle crashes after cannabis use. , 2004, Drug and alcohol dependence.

[68]  Christine M. Wickens,et al.  Self-Reported Collision Risk Associated With Cannabis Use and Driving After Cannabis Use Among Ontario Adults , 2010, Traffic injury prevention.

[69]  T. Friede,et al.  Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis , 2005, Neurology.

[70]  M. Barnes.  Sativex®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain , 2006, Expert opinion on pharmacotherapy.

[71]  V. Clark,et al.  Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. , 2015, The American review of respiratory disease.